DocuSign (DOCU) 10-Q 6 Dec 24 2025 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Oct. 31, 2024	Nov. 29, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2024
Document Transition Report	false
Entity File Number	001-38465
Entity Registrant Name	DOCUSIGN, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	91-2183967
Entity Address, Address Line One	221 Main St.
Entity Address, Address Line Two	Suite 1550
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	415
Local Phone Number	489-4940
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	DOCU
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		202,023,141
Entity Central Index Key	0001261333
Current Fiscal Year End Date	--01-31
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q3

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Current assets
Cash and cash equivalents	$ 610,870	$ 797,060
Investments—current	331,506	248,402
Accounts receivable, net of allowance for doubtful accounts of $9,556 and $5,499 as of October 31, 2024 and January 31, 2024	300,444	439,299
Contract assets—current	13,645	15,922
Prepaid expenses and other current assets	75,412	66,984
Total current assets	1,331,877	1,567,667
Investments—noncurrent	112,805	121,977
Property and equipment, net	278,623	245,173
Operating lease right-of-use assets	113,365	123,188
Goodwill	455,678	353,138
Intangible assets, net	83,307	50,905
Deferred contract acquisition costs—noncurrent	445,987	409,627
Deferred tax assets—noncurrent	816,538	2,031
Other assets—noncurrent	132,028	97,584
Total assets	3,770,208	2,971,290
Current liabilities
Accounts payable	18,144	19,029
Accrued expenses and other current liabilities	94,591	104,037
Accrued compensation	158,779	195,266
Contract liabilities—current	1,307,749	1,320,059
Operating lease liabilities—current	19,507	22,230
Total current liabilities	1,598,770	1,660,621
Contract liabilities—noncurrent	22,931	21,980
Operating lease liabilities—noncurrent	111,132	120,823
Deferred tax liability—noncurrent	19,303	16,795
Other liabilities—noncurrent	28,695	21,332
Total liabilities	1,780,831	1,841,551
Commitments and contingencies (Note 9)
Stockholders’ equity
Preferred stock, $0.0001 par value; 10,000 shares authorized, 0 shares issued and outstanding as of October 31, 2024 and January 31, 2024	0	0
Common stock, $0.0001 par value; 500,000 shares authorized, 202,000 shares outstanding as of October 31, 2024; 500,000 shares authorized, 205,326 shares outstanding as of January 31, 2024	20	21
Treasury stock, at cost: 30 shares as of October 31, 2024; 18 shares as of January 31, 2024	(2,871)	(2,164)
Additional paid-in capital	3,225,481	2,821,461
Accumulated other comprehensive loss	(23,682)	(19,360)
Accumulated deficit	(1,209,571)	(1,670,219)
Total stockholders’ equity	1,989,377	1,129,739
Total liabilities and equity	$ 3,770,208	$ 2,971,290

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Statement of Financial Position [Abstract]
Accounts receivable, allowance for credit loss	$ 9,556	$ 5,499
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares outstanding (in shares)	202,000,000	205,326,000
Treasury stock, shares (in shares)	30,000	18,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Revenue:
Total revenue	$ 754,820	$ 700,421	$ 2,200,487	$ 2,049,496
Cost of revenue:
Total cost of revenue	156,537	142,645	461,448	424,714
Gross profit	598,283	557,776	1,739,039	1,624,782
Operating expenses:
Sales and marketing	290,597	292,473	859,705	867,916
Research and development	151,101	136,640	432,992	387,964
General and administrative	97,555	108,215	277,162	316,910
Restructuring and other related charges	0	710	29,721	30,293
Total operating expenses	539,253	538,038	1,599,580	1,603,083
Income from operations	59,030	19,738	139,459	21,699
Interest expense	(462)	(1,577)	(1,150)	(5,135)
Interest income and other income, net	13,006	17,673	41,745	47,373
Income before provision for (benefit from) income taxes	71,574	35,834	180,054	63,937
Provision for (benefit from) income taxes	9,151	(2,971)	(804,340)	17,198
Net income	$ 62,423	$ 38,805	$ 984,394	$ 46,739
Net income per share attributable to common stockholders:
Basic (in usd per share)	$ 0.31	$ 0.19	$ 4.81	$ 0.23
Diluted (in usd per share)	$ 0.30	$ 0.19	$ 4.69	$ 0.23
Weighted-average shares used in computing net income per share:
Basic (in shares)	203,567	204,456	204,674	203,609
Diluted (in shares)	208,706	208,054	209,755	208,317
Comprehensive income:
Foreign currency translation gain (loss), net of tax	$ 285	$ (10,029)	$ (5,033)	$ (7,523)
Unrealized gains on investments, net of tax	581	1,078	711	2,032
Other comprehensive income (loss)	866	(8,951)	(4,322)	(5,491)
Comprehensive income	63,289	29,854	980,072	41,248
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense			460,388	455,831
Sales and marketing
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	49,347	53,715	154,396	150,604
Research and development
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	53,184	48,310	150,816	129,458
General and administrative
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	31,070	36,337	91,239	111,271
Restructuring and other related charges
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	0	8	4,836	4,996
Subscription
Revenue:
Total revenue	734,693	682,352	2,143,542	1,991,026
Cost of revenue:
Total cost of revenue	134,587	114,227	393,561	339,354
Subscription | Cost of revenue
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	14,862	13,705	44,636	38,143
Professional services and other
Revenue:
Total revenue	20,127	18,069	56,945	58,470
Cost of revenue:
Total cost of revenue	21,950	28,418	67,887	85,360
Professional services and other | Cost of revenue
Stock-based compensation expense included in costs and expenses:
Stock-based compensation expense	$ 4,765	$ 7,343	$ 14,465	$ 21,359

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023		201,904
Beginning balance at Jan. 31, 2023	$ 617,287	$ 20	$ 2,240,732	$ (1,785)	$ (22,996)	$ (1,598,684)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		769
Exercise of stock options	13,207		13,207
Settlement of restricted stock units (in shares)		5,415
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan (in shares)		(1,947)
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan	(98,912)		(98,533)	(379)
Employee stock purchase plan (in shares)		839
Employee stock purchase plan	$ 32,993		32,993
Repurchases of common stock (in shares)	(3,100)	(3,058)
Repurchases of common stock	$ (145,515)					(145,515)
Settlement of capped calls, net of related costs	23,688		23,688
Employee stock-based compensation	481,037		481,037
Net income	46,739					46,739
Other comprehensive income (loss), net	(5,491)				(5,491)
Ending balance (in shares) at Oct. 31, 2023		203,922
Ending balance at Oct. 31, 2023	965,033	$ 20	2,693,124	(2,164)	(28,487)	(1,697,460)
Beginning balance (in shares) at Jul. 31, 2023		203,197
Beginning balance at Jul. 31, 2023	847,759	$ 20	2,530,532	(2,027)	(19,536)	(1,661,230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		693
Exercise of stock options	12,375		12,375
Settlement of restricted stock units (in shares)		2,130
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan (in shares)		(752)
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan	(33,810)		(33,673)	(137)
Employee stock purchase plan (in shares)		419
Employee stock purchase plan	$ 14,603		14,603
Repurchases of common stock (in shares)	(1,800)	(1,765)
Repurchases of common stock	$ (75,035)					(75,035)
Employee stock-based compensation	169,287		169,287
Net income	38,805					38,805
Other comprehensive income (loss), net	(8,951)				(8,951)
Ending balance (in shares) at Oct. 31, 2023		203,922
Ending balance at Oct. 31, 2023	$ 965,033	$ 20	2,693,124	(2,164)	(28,487)	(1,697,460)
Beginning balance (in shares) at Jan. 31, 2024	205,326	205,326
Beginning balance at Jan. 31, 2024	$ 1,129,739	$ 21	2,821,461	(2,164)	(19,360)	(1,670,219)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	661	660
Exercise of stock options	$ 11,346		11,346
Settlement of restricted stock units (in shares)		6,869
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan (in shares)		(2,496)
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan	(136,699)		(135,992)	(707)
Employee stock purchase plan (in shares)		862
Employee stock purchase plan	$ 35,314		35,314
Repurchases of common stock (in shares)	(9,200)	(9,221)
Repurchases of common stock	$ (523,747)	$ (1)				(523,746)
Employee stock-based compensation	493,352		493,352
Net income	984,394					984,394
Other comprehensive income (loss), net	$ (4,322)				(4,322)
Ending balance (in shares) at Oct. 31, 2024	202,000	202,000
Ending balance at Oct. 31, 2024	$ 1,989,377	$ 20	3,225,481	(2,871)	(23,682)	(1,209,571)
Beginning balance (in shares) at Jul. 31, 2024		202,296
Beginning balance at Jul. 31, 2024	1,961,406	$ 20	3,087,650	(2,670)	(24,548)	(1,099,046)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		576
Exercise of stock options	10,257		10,257
Settlement of restricted stock units (in shares)		2,640
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan (in shares)		(934)
Tax withholding on net share settlement of restricted stock units and employee stock purchase plan	(52,453)		(52,252)	(201)
Employee stock purchase plan (in shares)		298
Employee stock purchase plan	$ 15,124		15,124
Repurchases of common stock (in shares)	(2,900)	(2,876)
Repurchases of common stock	$ (172,948)					(172,948)
Employee stock-based compensation	164,702		164,702
Net income	62,423					62,423
Other comprehensive income (loss), net	$ 866				866
Ending balance (in shares) at Oct. 31, 2024	202,000	202,000
Ending balance at Oct. 31, 2024	$ 1,989,377	$ 20	$ 3,225,481	$ (2,871)	$ (23,682)	$ (1,209,571)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands		9 Months Ended
		Oct. 31, 2024	Oct. 31, 2023
Cash flows from operating activities:
Net income		$ 984,394	$ 46,739
Adjustments to reconcile net income provided by operating activities:
Depreciation and amortization		79,097	71,429
Amortization of deferred contract acquisition and fulfillment costs		172,731	147,781
Amortization of debt discount and transaction costs		415	3,722
Non-cash operating lease costs		14,463	16,499
Stock-based compensation expense		460,388	455,831
Deferred income taxes		(817,886)	7,265
Other		6,472	(1,353)
Changes in operating assets and liabilities:
Accounts receivable		130,691	152,902
Prepaid expenses and other current assets		(8,300)	(7,957)
Deferred contract acquisition and fulfillment costs		(214,548)	(176,510)
Other assets		(16,118)	(14,019)
Accounts payable		(1,514)	(9,089)
Accrued expenses and other liabilities		(7,146)	2,372
Accrued compensation		(41,128)	(4,368)
Contract liabilities		(16,431)	36,876
Operating lease liabilities		(16,220)	(19,292)
Net cash provided by operating activities		709,360	708,828
Cash flows from investing activities:
Cash paid for acquisition, net of acquired cash		(143,611)	0
Purchases of marketable securities		(333,537)	(203,346)
Maturities of marketable securities		265,834	251,517
Purchases of strategic and other investments		(625)	(520)
Purchases of property and equipment		(68,646)	(70,277)
Net cash used in investing activities		(280,585)	(22,626)
Cash flows from financing activities:
Repayments of convertible senior notes		0	(37,083)
Repurchases of common stock		(521,803)	(145,515)
Settlement of capped calls, net of related costs		0	23,688
Payment of tax withholding obligation on net RSU settlement and ESPP purchase		(132,134)	(98,296)
Proceeds from exercise of stock options		11,346	13,207
Proceeds from employee stock purchase plan		35,314	32,994
Net cash used in financing activities		(607,277)	(211,005)
Effect of foreign exchange on cash, cash equivalents and restricted cash		(2,239)	(4,897)
Net increase (decrease) in cash, cash equivalents and restricted cash		(180,741)	470,300
Cash, cash equivalents and restricted cash at beginning of period	[1]	801,499	723,201
Cash, cash equivalents and restricted cash at end of period	[1]	$ 620,758	$ 1,193,501
[1] $9.9 million and $4.4 million of restricted cash was included in Prepaid expenses and other current assets and Other assets—noncurrent at October 31, 2024 and January 31, 2024. $4.9 million and $1.3 million of restricted cash was included in Prepaid expenses and other current assets and in Other assets—noncurrent at October 31, 2023 and January 31, 2023.

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Statement of Cash Flows [Abstract]
Restricted cash	$ 9,900	$ 4,900	$ 4,400	$ 1,300
Supplemental disclosure:
Cash paid for interest	0	185
Cash paid for operating lease liabilities	20,885	27,115
Cash paid for income taxes	17,377	8,747
Non-cash investing and financing activities:
Property and equipment in accounts payable and accrued expenses and other current liabilities	2,036	1,318
Operating lease right-of-use assets exchanged for lease obligations	4,739	1,573
Excise tax payable on net stock repurchase	$ 1,943	$ 0

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Organization and Description of Business Docusign, Inc. (“we,” “our”, “us”, “Docusign”, or “Company”) was incorporated in the State of Washington in April 2003. We merged with and into Docusign, Inc., a Delaware corporation, in March 2015. Docusign offers solutions that address agreement workflows and digital transformation. Docusign’s core offerings, including the IAM platform, the world’s leading electronic signature, and contract lifecycle management (“CLM”) solutions, allow organizations to boost productivity, accelerate contract review cycles, and transform agreement data into insights and actions, while providing a better customer experience. For example, Docusign’s innovative IAM platform automates agreement workflows, uncovers actionable insights, and leverages artificial intelligence (“AI”) capabilities, which enables organizations to create, commit to, and manage agreements, from virtually anywhere in the world, securely. Basis of Presentation and Principles of Consolidation Our condensed consolidated financial statements include those of Docusign, Inc. and our subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The accompanying condensed consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) for interim financial information. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, these unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our fiscal 2024 Annual Report on Form 10-K. Our condensed consolidated financial statements are unaudited and have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and, in our opinion, include all adjustments of a normal recurring nature necessary for the fair statement of our financial position, results of operations and cash flows. Our condensed consolidated balance sheet as of January 31, 2024 was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The results of operations for the three and nine months ended October 31, 2024 are not necessarily indicative of the results to be expected for the year ending January 31, 2025 . O ur fiscal year ends on January 3 1. References to fiscal 2025, for example, are to the fiscal year ending January 31, 2025 . Certain prior year amounts have been reclassified to conform to current year presentation. These amounts were not material to any of the prior periods presented. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the condensed consolidated financial statements and notes thereto. Significant items subject to such estimates and assumptions made by management include, but are not limited to, the determination of: • the fair value of intangible assets acquired in business combinations; • the average period of benefit associated with deferred contract acquisition costs and fulfillment costs; • the fair value of certain stock awards issued; • the useful life and recoverability of long-lived assets; • the discount rate used for operating leases; • the recognition and measurement of loss contingencies; and • the recognition, measurement and valuation of deferred income taxes. Significant Accounting Policies There have been no changes to our significant accounting policies described in our fiscal 2024 Annual Report on Form 10-K that have had a material impact on our condensed consolidated financial statements and related notes. Recent Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which enhances disclosures required for operating segments. ASU 2023-07 expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. All disclosure requirements of ASU 2023-07 are required for entities with a single reportable segment. ASU 2023-07 is effective for annual filings for the Company’s fiscal year beginning February 1, 2024, and interim filings for the fiscal year beginning February 1, 2025, and should be applied on a retrospective basis to all periods presented. We are currently evaluating the effect of adopting ASU 2023-07 on our financial statement disclosures. In December 2023, the FASB issued Accounting Standards Update 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), amending existing income tax disclosure guidance, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation. ASU 2023-09 is effective for annual reporting periods beginning after December 15, 2024, with early adoption permitted and can be applied on either a prospective or retrospective basis. We are currently evaluating the effect of adopting ASU 2023-09 on our income tax disclosures. In March 2024, the SEC adopted the final rules under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors, which requires registrants to provide certain climate-related information in their registration statements and annual reports. As it pertains to the financial statements, the final rules require the financial statement footnotes to include certain disclosures regarding the amounts of expenses (or capitalized costs) incurred that relate to severe weather events and other natural conditions, as well as other disclosures regarding the material impact on financial estimates and assumptions of severe weather events and other natural conditions or disclosed targets or disclosed targets or transition plans. It also requires disclosure of financial statement amounts related to carbon offsets and renewable energy credits. The disclosure requirements will be phased in beginning with our annual filing for the fiscal year ending January 31, 2026. In April 2024, the SEC issued an order staying these rules pending the completion of judicial review of litigation challenging the validity of the rules. We are currently evaluating the disclosure impact of adoption of the standard on our consolidated financial statements. In November 2024, the FASB issued Accounting Standards Update 2024-03, "Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40)" (“ASU 2024-03”), which requires more detailed information about the types of expenses included in certain expense captions presented on the consolidated statements of operations. Additionally, this amendment requires the disclosure of a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively and the disclosure of the total amount of selling expenses. ASU 2024-03 is effective for annual filings for the Company's fiscal year beginning February 1, 2027, and interim filings for the fiscal year beginning February 1, 2028, and can be applied either prospectively or retrospectively. Early adoption is permitted. We are currently evaluating the effect of adopting ASU 2024-03 on our financial statements. We have not adopted accounting pronouncements during the three and nine months ended October 31, 2024.

Revenue

Revenue	9 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Subscription revenue is recognized over time and accounted for approximately 97% of our revenue in each of the three and nine month periods ended October 31, 2024 and 2023. Performance Obligations As of October 31, 2024, the amount of the transaction price allocated to remaining performance obligations for contracts greater than one year was $2.3 billion. We expect to recognize 56% of the transaction price allocated to remaining performance obligations within the 12 months following October 31, 2024 in our condensed consolidated statement of operations and comprehensive income. Contract Balances Contract assets represent amounts for which we have recognized revenue, pursuant to our revenue recognition policy, for contracts that have not yet been invoiced to our customers where there is a remaining performance obligation, typically for multi-year arrangements. Total contract assets were $13.6 million and $15.9 million as of October 31, 2024 and January 31, 2024. The change in contract assets reflects the difference in timing between our satisfaction of remaining performance obligations and our contractual right to bill our customers. Contract liabilities consist of deferred revenue and payments received in advance of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. For the nine months ended October 31, 2024 and 2023, we recognized revenue of $1.2 billion and $1.1 billion that was included in the corresponding contract liability balance at the beginning of the periods presented. We receive payments from customers based upon contractual billing schedules. We record accounts receivable when the right to consideration becomes unconditional. Payment terms on invoiced amounts are typically 30 days. Geographic Information Revenue by geography is based on the address of the customer as specified in our master subscription agreements with our customers. Revenue by geographic area was as follows: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2024 2023 2024 2023 U.S. $ 543,294 $ 515,050 $ 1,585,472 $ 1,516,092 International 211,526 185,371 615,015 533,404 Total revenue $ 754,820 $ 700,421 $ 2,200,487 $ 2,049,496 The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Nine Months Ended October 31, (in thousands) 2024 2023 Deferred Contract Acquisition Costs: Beginning balance $ 409,658 $ 355,389 Additions to deferred contract acquisition costs 183,040 143,321 Amortization of deferred contract acquisition costs (143,769) (114,151) Cumulative translation adjustment (2,942) (1,212) Ending balance $ 445,987 $ 383,347 Deferred Contract Fulfillment Costs: Beginning balance $ 22,525 $ 21,076 Additions to deferred contract fulfillment costs 31,508 33,189 Amortization of deferred contract fulfillment costs (28,962) (33,630) Cumulative translation adjustment 73 (268) Ending balance $ 25,144 $ 20,367

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table summarizes our financial assets that are measured at fair value on a recurring basis: October 31, 2024 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 131,736 $ — $ — $ 131,736 Level 2: Cash equivalents (1) Commercial paper 1,982 — (1) 1,981 Available-for-sale securities Commercial paper 66,970 28 (16) 66,982 Corporate notes and bonds 363,651 625 (416) 363,860 U.S. governmental securities 13,485 2 (18) 13,469 Level 2 total 446,088 655 (451) 446,292 Total $ 577,824 $ 655 $ (451) $ 578,028 January 31, 2024 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 298,517 $ — $ — $ 298,517 Level 2: Cash equivalents (1) Commercial paper 43,845 — (9) 43,836 U.S. government agency securities 9,968 — (1) 9,967 Available-for-sale securities Commercial paper 42,958 2 (25) 42,935 Corporate notes and bonds 299,166 262 (670) 298,758 U.S. governmental securities 28,752 — (66) 28,686 Level 2 total 424,689 264 (771) 424,182 Total $ 723,206 $ 264 $ (771) $ 722,699 (1) Included in “cash and cash equivalents” in our consolidated balance sheets as of October 31, 2024 and January 31, 2024, in addition to cash of $477.2 million and $444.8 million. We use quoted prices in active markets for identical assets to determine the fair value of our Level 1 investments. The fair value of our Level 2 investments is determined using pricing based on quoted market prices or alternative market observable inputs . The fair values of our available-for-sale securities as of October 31, 2024, by remaining contractual maturities, were as follows (in thousands): Due in one year or less $ 331,506 Due in one to two years 112,805 $ 444,311 As of October 31, 2024 and January 31, 2024, securities in an unrealized loss position were, individually and in aggregate, not material. An allowance for credit losses was deemed unnecessary for these securities, given the extent of the unrealized loss positions as well as the issuers' high credit ratings and consistent payment history. We had no liabilities measured at fair value on a recurring basis as of October 31, 2024 and January 31, 2024.

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net consisted of the following: (in thousands) October 31, 2024 January 31, 2024 Computer and network equipment $ 137,477 $ 142,241 Software, including capitalized software development costs 255,047 168,584 Furniture and office equipment 19,231 18,196 Leasehold improvements 63,776 58,230 475,531 387,251 Less: Accumulated depreciation (293,152) (244,270) 182,379 142,981 Work in progress 96,244 102,192 Total $ 278,623 $ 245,173 Depreciation and amortization expense associated with property and equipment was $20.7 million and $18.6 million for the three months ended October 31, 2024 and 2023, and $61.3 million and $56.8 million for the nine months ended October 31, 2024 and 2023. This included amortization expense related to capitalized internally developed software costs of $14.3 million and $9.5 million for the three months ended October 31, 2024 and 2023, and $39.4 million and $25.1 million for the nine months ended October 31, 2024 and 2023 . For the three months ended October 31, 2024 and 2023, we capitalized $29.8 million and $26.5 million of internally developed software, including $10.0 million and $8.8 million of capitalized stock-based compensation expense in the three months ended October 31, 2024 and 2023. For the nine months ended October 31, 2024 and 2023 , we capitalized $81.3 million and $70.4 million of internally developed software, including $27.7 million and $22.5 million of capitalized stock-based compensation expense in the nine months ended October 31, 2024 and 2023 .

Acquisitions

Acquisitions	9 Months Ended
	Oct. 31, 2024
Business Combinations [Abstract]
Acquisitions	Acquisitions Acquisition of DocuSmart, Inc. d/b/a Lexion On May 31, 2024 (“Acquisition Date”), we acquired 100% of the outstanding equity interests of DocuSmart, Inc. (“Lexion”), an AI-powered contract management platform which features intelligent contract repository and agreement workflow automation and reporting. We expect to integrate Lexion’s technology and capabilities comprehensively across Docusign solutions, including advanced document understanding for contract reviews, negotiations, insights and analysis, to better enable organizations to create, commit to, and manage agreements. The results of Lexion’s operations have been included in the accompanying consolidated financial statements since the Acquisition Date. The acquisition purchase consideration, in accordance with ASC 805, totaled $154.0 million and was paid in cash. The Company paid $17.4 million of the consideration to an escrow account held for 18 months by a third party for post-closing indemnification obligations. We accounted for the transaction as a business combination using the acquisition method of accounting. We allocated the purchase price to the tangible and identifiable intangible assets acquired and liabilities assumed based on their respective estimated fair values on the Acquisition Date. Fair values were determined using the replacement cost method. Excess purchase price consideration was recorded as goodwill and is primarily attributable to the assembled workforce and expanded market opportunities when integrating Lexion’s intelligent contract repository and agreement workflow automation capabilities within Docusign’s IAM platform. The values assigned to the assets acquired and liabilities assumed are based on preliminary estimates of fair value available as of the date of this Quarterly Report on Form 10-Q. We continue to collect information with regards to our estimates and assumptions, including potential liabilities, contingencies, and the allocation of the purchase price. We will record adjustments to the fair value of the net assets acquired, liabilities assumed and goodwill within the measurement period, if necessary. The following table summarizes preliminary allocation of purchase consideration to assets acquired and liabilities assumed based on their respective estimated fair values as of the date of acquisition: (in thousands) May 31, 2024 Cash and cash equivalents $ 10,409 Accounts receivable, net 1,741 Goodwill 103,352 Intangible assets, net 50,200 Contract liabilities — current (5,071) Deferred tax liability (5,862) Accrued expenses and other current liabilities (749) Total purchase consideration $ 154,020 None of the goodwill recognized upon acquisition is deductible for U.S. federal income tax purposes. The estimated useful lives of intangible assets, primarily based on the expected period of benefit to us, and fair values of the identifiable intangible assets at Acquisition Date were as follows: (in thousands, except years) Estimated Fair Value Expected Useful Life Existing technology $ 29,900 5.0 years Customer relationships—subscription 20,300 7.0 years Total intangible assets $ 50,200 5.8 years Additionally, the purchase agreement provides for $19.1 million of deferred compensation for key employees for which post acquisition employment service is required. The deferred compensation was paid into an escrow account at closing and recorded as prepaid asset that will amortize into compensation expense on a straight-line basis over the three We granted certain continuing employees and founders of Lexion restricted stock units (“RSUs”) with an aggregate grant date fair value of $34.8 million that will be accounted for as a post-acquisition compensation expense over the vesting period. During the nine months ended October 31, 2024, we incurred acquisition related expenses of $4.3 million which are recognized within general and administrative expenses in the consolidated statement of operations. The following unaudited pro forma information has been prepared for illustrative purposes only and assumes the acquisition occurred on February 1, 2023. It includes pro forma adjustments related to the amortization of acquired intangible assets, share-based compensation expense, deferred compensation, and transaction related expenses. The impact of pro forma adjustments during the three and nine months ended October 31, 2024 is not material. For the purpose of computing the pro forma tax effects of the acquisition, we applied the historical annual effective tax rate for the three and nine months ended October 31, 2023 to the combined entity results. The unaudited pro forma results have been prepared based on estimates and assumptions, which we believe are reasonable, however, they are not necessarily indicative of the consolidated results of operations had the acquisition occurred on February 1, 2023, or of future results of operations: (in thousands) (unaudited) Three Months Ended October 31, Nine Months Ended October 31, 2023 2023 Net income/(loss) 21,799 23,916

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	9 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	Goodwill and Intangible Assets, Net The changes in the carrying amount of goodwill were as follows (in thousands): Balance at January 31, 2024 $ 353,138 Additions—Lexion 103,352 Cumulative translation adjustment (812) Balance at October 31, 2024 $ 455,678 Intangible assets consisted of the following: As of October 31, 2024 As of January 31, 2024 (in thousands, except years) Weighted-average Remaining Useful Life (Years) Acquisition-related Intangibles, Gross Accumulated Amortization Acquisition-related Intangibles, Net Acquisition-related Intangibles, Gross Accumulated Amortization Acquisition-related Intangibles, Net Existing technology 4.0 $ 106,094 $ (74,479) $ 31,615 $ 76,194 $ (65,777) $ 10,417 Customer contracts & related relationships 5.1 130,382 (70,043) 60,339 110,082 (60,947) 49,135 Other 0.0 22,534 (22,534) — 22,534 (22,534) — 4.7 $ 259,010 $ (167,056) 91,954 $ 208,810 $ (149,258) 59,552 Cumulative translation adjustment (8,647) (8,647) Total $ 83,307 $ 50,905 Amortization of finite-lived intangible assets was as follows: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2024 2023 2024 2023 Cost of subscription revenue $ 3,566 $ 2,070 $ 8,703 $ 6,787 Sales and marketing 3,354 2,629 9,096 7,888 Total $ 6,920 $ 4,699 $ 17,799 $ 14,675 As of October 31, 2024, future amortization of finite-lived intangibles that will be recorded is estimated as follows, excluding cumulative translation adjustment: Fiscal Period: Amount (in thousands) 2025, remainder $ 6,919 2026 21,535 2027 19,398 2028 16,938 2029 13,191 Thereafter 13,973 Total $ 91,954

Deferred Contract Acquisition a

Deferred Contract Acquisition and Fulfillment Costs	9 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
Deferred Contract Acquisition and Fulfillment Costs	Revenue Subscription revenue is recognized over time and accounted for approximately 97% of our revenue in each of the three and nine month periods ended October 31, 2024 and 2023. Performance Obligations As of October 31, 2024, the amount of the transaction price allocated to remaining performance obligations for contracts greater than one year was $2.3 billion. We expect to recognize 56% of the transaction price allocated to remaining performance obligations within the 12 months following October 31, 2024 in our condensed consolidated statement of operations and comprehensive income. Contract Balances Contract assets represent amounts for which we have recognized revenue, pursuant to our revenue recognition policy, for contracts that have not yet been invoiced to our customers where there is a remaining performance obligation, typically for multi-year arrangements. Total contract assets were $13.6 million and $15.9 million as of October 31, 2024 and January 31, 2024. The change in contract assets reflects the difference in timing between our satisfaction of remaining performance obligations and our contractual right to bill our customers. Contract liabilities consist of deferred revenue and payments received in advance of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. For the nine months ended October 31, 2024 and 2023, we recognized revenue of $1.2 billion and $1.1 billion that was included in the corresponding contract liability balance at the beginning of the periods presented. We receive payments from customers based upon contractual billing schedules. We record accounts receivable when the right to consideration becomes unconditional. Payment terms on invoiced amounts are typically 30 days. Geographic Information Revenue by geography is based on the address of the customer as specified in our master subscription agreements with our customers. Revenue by geographic area was as follows: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2024 2023 2024 2023 U.S. $ 543,294 $ 515,050 $ 1,585,472 $ 1,516,092 International 211,526 185,371 615,015 533,404 Total revenue $ 754,820 $ 700,421 $ 2,200,487 $ 2,049,496 The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Nine Months Ended October 31, (in thousands) 2024 2023 Deferred Contract Acquisition Costs: Beginning balance $ 409,658 $ 355,389 Additions to deferred contract acquisition costs 183,040 143,321 Amortization of deferred contract acquisition costs (143,769) (114,151) Cumulative translation adjustment (2,942) (1,212) Ending balance $ 445,987 $ 383,347 Deferred Contract Fulfillment Costs: Beginning balance $ 22,525 $ 21,076 Additions to deferred contract fulfillment costs 31,508 33,189 Amortization of deferred contract fulfillment costs (28,962) (33,630) Cumulative translation adjustment 73 (268) Ending balance $ 25,144 $ 20,367

Debt

Debt	9 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt Convertible Senior Notes In September 2018, we issued $575.0 million in aggregate principal amount of the 0.5% Convertible Senior Notes due in 2023 (“2023 Notes”). The net proceeds from the issuance of the 2023 Notes were $560.8 million after deducting the initial purchasers’ discounts and transaction costs. In January 2021, we issued $690.0 million in aggregate principal amount of the 0% Convertible Senior Notes due in 2024 (“2024 Notes,” and together with the 2023 Notes, the “Notes”). The net proceeds from the issuance of the 2024 Notes were $677.3 million after deducting the initial purchasers’ discounts and transaction costs. The 2023 Notes and 2024 Notes were extinguished, and all outstanding amounts were repaid in full during the third and fourth quarters of fiscal 2024, respectively. We repaid in cash $37.1 million and $689.9 million in aggregate principal amount of the 2023 Notes and 2024 Notes. The effective interest rate on the 2023 Notes was 1.0%. The effective interest rate on the 2024 Notes was 0.6%. Interest expense recognized related to the Notes was as follows: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2024 2023 2024 2023 Contractual interest expense $ — $ 22 $ — $ 425 Amortization of transaction costs — 1,089 — 3,308 Total $ — $ 1,111 $ — $ 3,733 Capped Calls To minimize the potential economic dilution to our common stock upon conversion of the Notes, we entered into privately negotiated capped call transactions (“Capped Calls”) with certain counterparties. In the first quarter of fiscal 2024, we unwound $23.7 million of the Capped Calls in relation to our 2023 Notes and received cash from the counterparties. All remaining Capped Calls associated with the 2023 Notes and 2024 Notes expired during the third and fourth quarters of fiscal 2024, respectively. Impact on Net Income Per Share In periods when we have net income, the shares of our common stock subject to the Notes outstanding during the period are included in our diluted earnings per share under the if-converted method. In the three and nine months ended October 31, 2023, the Capped Calls were excluded from the calculation of diluted earnings per share, as they were antidilutive. Revolving Credit Facility In January 2021, we entered into a credit agreement, as subsequently amended in May 2023, with a syndicate of banks. The credit agreement extended a senior secured revolving credit facility (the “Credit Facility”) to us in an aggregate principal amount of $500.0 million, which amount may be increased by an additional $250.0 million subject to the terms of the credit agreement. We may use the proceeds of future borrowings under the credit facility to finance working capital, for capital expenditures and for other general corporate purposes, including permitted acquisitions. The Credit Facility matures in January 2026 and requires us to comply with customary affirmative and negative covenants. We were in compliance with all covenants as of October 31, 2024. As of October 31, 2024, there were no outstanding borrowings under the Credit Facility. The Credit Facility is subject to customary fees for loan facilities of this type, including ongoing commitment fees at a rate between 0.25% and 0.30% per annum on the daily undrawn balance.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies As of October 31, 2024, we had unused letters of credit outstanding totaling $0.6 million, the majority of which are associated with our various operating leases. We have entered into certain noncancelable contractual arrangements that require future purchases of goods and services. These arrangements primarily relate to cloud infrastructure support and sales and marketing activities. As of October 31, 2024, our future noncancelable minimum payments due under these contractual obligations with a remaining term of more than one year were as follows: Fiscal Period: Amount (in thousands) 2025, remainder $ 12,095 2026 52,740 2027 11,490 2028 1,663 2029 1,138 Thereafter 483 Total $ 79,609 We entered into agreements with public cloud computing service providers with minimum commitments through fiscal 2027 and 2028. As of October 31, 2024 our remaining commitments under these agreements are $13.2 million and $83.1 million, respectively, which are excluded from the table above. Indemnification We enter into indemnification provisions under our agreements with customers and other companies in the ordinary course of business, including business partners, contractors and parties performing our research and development. Pursuant to these arrangements, we agree to indemnify and defend the indemnified party for certain claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party claims because of our activities. The duration of these indemnification agreements is generally perpetual. The maximum potential amount of future payments we could be required to make under these indemnification clauses or agreements is not determinable. Historically, we have not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, we believe the fair value of these indemnification agreements is not material as of October 31, 2024, and January 31, 2024. We maintain commercial general liability insurance and product liability insurance to offset certain of our potential liabilities under these indemnification agreements. We have entered into indemnification agreements with each of our directors, executive officers and certain other officers. These agreements require us to indemnify such individuals, to the fullest extent permitted by Delaware law, for certain liabilities to which they may become subject as a result of their affiliation with us. Claims and Litigation From time to time, we may be subject to legal proceedings, claims, investigations or other contingencies in the ordinary course of business. If we are unsuccessful in defending, or if we determine to settle, any of these matters, we may be required to pay substantial sums, be subject to injunction and/or be required to change how we operate our business, which could have a material adverse impact on our financial position or results of operations. Legal costs associated with litigation are expensed as incurred. Unless otherwise stated, we are unable to reasonably estimate the loss or a range of possible loss for the matters described below. In certain instances, we may be unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. We review loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether we can make a reasonable estimate of the loss or range of loss. When we determine that a loss from a claim is probable and reasonably estimable, we record a liability for an estimated amount. We also provide disclosure when we determine it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Because these issues are often subject to substantial uncertainty, the probability of a loss (if any) and/or the estimated amount of a loss are difficult to ascertain. While it is not feasible to predict the outcome of all proceedings and exposures with certainty, we believe the final outcome of these matters, including the cases described below, will not have a material adverse effect on our business, consolidated financial position, results of operations or cash flows. Docusign, Inc. Securities Litigation and Related Derivative Litigation On February 8, 2022, a putative securities class action was filed in the U.S. District Court for the Northern District of California, captioned Weston v. Docusign, Inc., et al., Case No. 3:22-cv-00824, naming Docusign and certain of our then-current and former officers as defendants (“Weston Action”). An amended complaint was filed on July 8, 2022. As amended, the suit purports to allege claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 promulgated thereunder, based on allegedly false and misleading statements about our business and prospects during the course of the COVID-19 pandemic. As amended, the suit is purportedly brought on behalf of purchasers of our securities between June 4, 2020 and June 9, 2022. Our motion to dismiss was denied by the U.S. District Court on April 18, 2023 and we have continued to defend the case since that time. On September 25, 2024, an individual action asserting similar claims against the same defendants, captioned TIAA-CREF Investment Management, LLC, et al. v. Docusign, Inc., et al., Case No. 3:24-cv-06749, was filed in the U.S. District Court for the Northern District of California (“TIAA Action”). On November 8, 2024, the Court stayed the TIAA Action pending the outcome of the Weston Action. On November 27, 2024, plaintiffs voluntarily dismissed the TIAA Action. Eight putative shareholder derivative cases have been filed containing allegations based on or similar to those in the securities class action (Weston Action). The cases were filed on May 17, 2022, in the U.S. District Court for the District of Delaware, captioned Pottetti v. Springer, et al., Case No. 1:22-cv-00652; on May 19, 2022, in the U.S. District Court for the Northern District of California, captioned Lapin v. Springer, et al., Case No. 3:22-cv-02980; on May 20, 2022, in the U.S. District Court for the Northern District of California, captioned Votto v. Springer, et al., Case No. 3:22-cv-02987; on September 20, 2022, in the U.S. District Court for the Northern District of California, captioned Fox v. Springer, et al., Case No. 3:22-cv-05343; on March 7, 2024, in the Delaware Court of Chancery, captioned Roy v. Alhadeff, et al., Case No. C.A. 2024-0223-PAF; on April 9, 2024, in the U.S. District Court for the Northern District of California, captioned Alexander v. Springer, et al., Case No. 3:24-cv-02139; on April 11, 2024, in the Delaware Court of Chancery, captioned Ingrao v. Beer, et al., Case No. C.A. 2024-0382-PAF; and on May 28, 2024, in the Delaware Court of Chancery, captioned Jordan v. Springer, et al., Case No. C.A. 2024-0564-PAF. Each case is allegedly brought on the Company’s behalf. The suits name the Company as a nominal defendant and, depending on the particular case, the members of our board of directors or, in certain instances, then-current or former officers, as defendants. While the complaints vary, they are based largely on the same underlying allegations as the securities class action suit described above (Weston Action), as well as, in certain instances, alleged insider trading. Collectively, these lawsuits purport to assert claims for, among other things, breach of fiduciary duty, aiding and abetting such breach, corporate waste, gross mismanagement, unjust enrichment, and under Sections 10(b) and 21D of the Securities Exchange Act of 1934. The complaints seek to recover unspecified damages and other relief on the Company’s behalf. By court order dated July 19, 2022, the first two cases in the Northern District of California (Lapin and Votto) have been consolidated and stayed in light of the securities class action and no response to the complaints in the action will be due unless and until the stay is lifted. The third case in the Northern District of California (Fox) was related to the other derivative suits and assigned to the same judge, and was similarly stayed by order of the court on December 2, 2022. The most recent case in the Northern District of California (Alexander) was also related to the other derivative suits and assigned to the same judge, and subsequently consolidated with Lapin and Votto and stayed by order of the court on May 8, 2024. The Delaware suit (Pottetti) was voluntarily dismissed on September 1, 2022, and then re-filed in the Delaware Court of Chancery on September 22, 2022, under the caption Pottetti v. Springer, et al., Case No. C.A. 2022-0852-PAF. The Delaware Court of Chancery issued an order on September 30, 2022, staying the action in light of the securities class action. On May 28, 2024, plaintiff filed a notice seeking to voluntarily dismiss the Delaware Court of Chancery Pottetti action. On June 14, 2024, the plaintiff in Pottetti moved to voluntarily dismiss that action and the Court granted the dismissal on June 17, 2024. On September 30, 2024, the newly filed suits (Roy, Ingrao, and Jordan) were consolidated and stayed in light of the securities class action, such that no response to the complaints would be due unless and until the stay is lifted. Docusign Civil Litigation On October 25, 2022, an action was filed in the Delaware Court of Chancery, captioned Daniel D. Springer v. Mary Agnes Wilderotter and Docusign, Inc., Civil Action No. 2022-0963-LWW, concerning Mr. Springer’s resignation from our board of directors. To avoid the cost and distraction of further litigation with Mr. Springer, we stipulated to entry of judgment in favor of Mr. Springer as to his disputed resignation and his status as a member of our board of directors. The Court of Chancery later dismissed the case. In addition, on January 26, 2023, Mr. Springer delivered a demand for arbitration before JAMS, a private alternative dispute resolution firm, captioned Daniel D. Springer v. Docusign, Inc. and Mary Agnes Wilderotter. The demand alleged that Mr. Springer was wrongfully terminated as Chief Executive Officer; asserted related claims against Docusign and Ms. Wilderotter, including defamation, withholding promised compensation and breach of contract. The arbitration hearing for this case took place in March 2024.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity Equity Incentive Plans We maintain three stock-based compensation plans: the 2018 Equity Incentive Plan (the “2018 Plan”), the Amended and Restated 2011 Equity Incentive Plan and the Amended and Restated 2003 Stock Plan. As of October 31, 2024, 38.9 million shares of our common stock were available for issuance under the 2018 Plan. Restricted Stock Units RSU activity for the nine months ended October 31, 2024 was as follows: (in thousands, except per share data) Number of Units Weighted-Average Grant Date Fair Value Unvested at January 31, 2024 26,700 $ 60.70 Granted 12,638 57.90 Vested (6,991) 69.14 Canceled (3,138) 66.67 Unvested at October 31, 2024 29,209 $ 56.67 As of October 31, 2024, our total unrecognized compensation cost related to RSUs was $1.2 billion. We expect to recognize this expense over the remaining weighted-average period of approximately 2.82 years. As of October 31, 2024, the grant date fair value of unvested RSUs subject to market-based and performance-based vesting conditions (“PSU”) was $154.8 million. The number of RSUs granted or canceled included in the table above reflects shares that could be eligible to vest at 100% of target for PSUs and includes adjustments for over or under achievement for PSUs granted in prior periods. Stock Options Option activity for the nine months ended October 31, 2024 was as follows: (in thousands, except years and per share data) Number of Options Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at January 31, 2024, all vested and exercisable 1,385 $ 17.39 2.63 $ 60,117 Exercised (661) 17.17 Canceled/expired (1) 13.43 Outstanding at October 31, 2024, all vested and exercisable 723 $ 17.61 1.94 $ 37,216 As of October 31, 2024, there was no remaining unrecognized compensation cost related to stock option grants. Employee Stock Purchase Plan The Employee Stock Purchase Plan (“ESPP”) allows eligible employees to purchase shares of our common stock at a discounted price, normally through payroll deductions, subject to the terms of the ESPP and applicable law. As of October 31, 2024, 11.8 million shares of our common stock were reserved for issuance under the ESPP. Compensation expense related to the ESPP was $3.3 million and $4.2 million for the three months ended October 31, 2024 and 2023, and $9.9 million and $12.8 million for the nine months ended October 31, 2024 and 2023. Stock Repurchase Program In March 2022, our board of directors authorized a stock repurchase program of up to $200.0 million of our outstanding common stock. Subsequently, in September 2023, our board of directors authorized an increase to our existing stock repurchase program for an additional amount of up to $300.0 million of our outstanding common stock. In May 2024, our board of directors authorized an increase to our existing stock repurchase program for an additional amount of up to $1.0 billion of our outstanding common stock. During the three months ended October 31, 2024, we repurchased and canceled 2.9 million shares of common stock for an aggregate amount of $172.9 million. During the nine months ended October 31, 2024, we repurchased and canceled 9.2 million shares of common stock for an aggregate amount of $523.7 million. The repurchase amount includes the 1% excise tax as a result of the Inflation Reduction Act (“IRA”). During the three months ended October 31, 2023, we repurchased and canceled 1.8 million shares of common stock for an aggregate amount of $75.0 million. During the nine months ended October 31, 2023, we repurchased and canceled 3.1 million shares of common stock for an aggregate amount of $145.5 million.

Restructuring and Other Related

Restructuring and Other Related Charges	9 Months Ended
	Oct. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Other Related Charges	Restructuring 2024 Restructuring Plan During the first quarter of fiscal 2024 , our board of directors authorized a restructuring plan (the “2024 Restructuring Plan”) designed to support our growth, scale and profitability objectives. We incurred costs associated with the 2024 Restructuring Plan related to employee termination benefits and other costs mainly in the first quarter of fiscal 2024. As of the second quarter of fiscal 2024, the 2024 Restructuring Plan had been substantially completed. 2025 Restructuring Plan During the first quarter of fiscal 2025 , our board of directors authorized a restructuring plan (the “2025 Restructuring Plan”) designed to strengthen and support our financial and operational efficiency while continuing to invest in product and related initiatives. We incurred costs associated with the 2025 Restructuring Plan related to employee termination benefits and other costs mainly in the first quarter of fiscal 2025. As of the second quarter of fiscal 2025, the 2025 Restructuring Plan had been substantially completed. These amounts are recorded to the Restructuring and other related charges within our consolidated statements of operations and comprehensive income as they are incurred. For the nine months ended October 31, 2024, restructuring and other related charges were $29.7 million for employee termination benefits, which included stock-based compensation expense of $4.8 million. For the nine months ended October 31, 2023, restructuring and other related charges were $30.3 million, and primarily composed of $28.7 million for employee termination benefits, which included stock-based compensation expense of $5.0 million. Restructuring liability activities during the nine months ended October 31, 2024: (in thousands) January 31, 2024 Accruals Cash Payments October 31, 2024 2024 Restructuring Plan Other 122 — (122) — Total $ 122 $ — $ (122) $ — 2025 Restructuring Plan Employee termination benefits $ — $ 24,874 $ (24,658) $ 216 Total $ — $ 24,874 $ (24,658) $ 216

Net Income per Share Attributab

Net Income per Share Attributable to Common Stockholders	9 Months Ended
	Oct. 31, 2024
Earnings Per Share [Abstract]
Net Income per Share Attributable to Common Stockholders	Net Income per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net income per share attributable to common stockholders for periods presented: Three Months Ended October 31, Nine Months Ended October 31, (in thousands, except per share data) 2024 2023 2024 2023 Numerator: Net income attributable to common stockholders, basic $ 62,423 $ 38,805 $ 984,394 $ 46,739 Add: Interest expense on convertible senior notes — $ 22 — 425 Net income attributable to common stockholders, diluted $ 62,423 $ 38,827 $ 984,394 $ 47,164 Denominator: Weighted-average common shares outstanding, basic 203,567 204,456 204,674 203,609 Effect of dilutive securities 5,139 3,598 5,081 4,708 Weighted-average common shares outstanding, diluted 208,706 208,054 209,755 208,317 Net income per share attributable to common stockholders: Basic $ 0.31 $ 0.19 $ 4.81 $ 0.23 Diluted $ 0.30 $ 0.19 $ 4.69 $ 0.23 Outstanding potentially dilutive securities that were excluded from the diluted per share calculations because they would have been antidilutive are as follows: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2024 2023 2024 2023 RSUs 2,879 22,913 3,011 13,045 ESPP 120 — 288 — Total antidilutive securities 2,999 22,913 3,299 13,045

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision or benefit from income taxes for interim periods is determined using an estimate of our annual effective tax rate as prescribed under Accounting Standards Codification (“ASC”) 740, “ Income Taxes ”, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, we update our estimate of the annual effective tax rate, and if our estimated tax rate changes, we make a cumulative adjustment, which results in a provision or benefit from income taxes in current or subsequent quarters. Our income tax provision expense was $9.2 million and benefit was $3.0 million for the three months ended October 31, 2024 and 2023. Our income tax benefit and income tax provision expense was $804.3 million and $17.2 million for the nine months ended October 31, 2024 and 2023. Included in the tax benefit for the nine months ended October 31, 2024 was a release of a net valuation allowance of $837.7 million, recorded as a discrete tax benefit during the three months ended July 31, 2024. We regularly assess the need for a valuation allowance on our deferred tax assets. In making this assessment, we consider both positive and negative evidence related to the likelihood of realization of the deferred tax assets to determine, based on the weight of available evidence, whether it is more likely than not that some or all the deferred tax assets will not be realized. Based on all available positive and negative evidence, having demonstrated sustained U.S. profitability which is objective and verifiable, and taking into account anticipated future earnings, we have concluded it is more likely than not that our U.S. federal and states deferred tax assets will be realizable, with the exception of certain federal deferred tax assets subject to limitation on use and our California deferred tax assets. When a change in valuation allowance is recognized during an interim period, the change in valuation allowance resulting from current year income is included in the annual effective tax rate and the release of valuation allowance supported by projections of future taxable income is recorded as a discrete tax benefit in the interim period. As of October 31, 2024, our gross unrecognized tax benefits totaled $71.1 million, excluding related accrued interest and penalties, of which $58.8 million would impact the effective tax rate if recognized. Our policy is to account for interest and penalties related to uncertain tax positions as a component of income tax provision. We do not expect material changes to our gross unrecognized tax benefits within the next 12 months.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Pay vs Performance Disclosure
Net income	$ 62,423	$ 38,805	$ 984,394	$ 46,739

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Oct. 31, 2024 shares	Oct. 31, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Name Title Adoption Date Earliest Sale Date Expiration Date Aggregate # of securities to be sold Aggregate # of securities to be purchased Allan Thygesen CEO / Director September 13, 2024 January 2, 2025 December 31, 2025 up to 160,000 N/A
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Allan Thygesen [Member]
Trading Arrangements, by Individual
Name	Allan Thygesen
Title	CEO / Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 13, 2024
Expiration Date	December 31, 2025
Arrangement Duration	363 days
Aggregate Available	160,000	160,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Principles of Consolidation	Our condensed consolidated financial statements include those of Docusign, Inc. and our subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The accompanying condensed consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) for interim financial information. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, these unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our fiscal 2024 Annual Report on Form 10-K.
Basis of Presentation	Our condensed consolidated financial statements are unaudited and have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and, in our opinion, include all adjustments of a normal recurring nature necessary for the fair statement of our financial position, results of operations and cash flows. Our condensed consolidated balance sheet as of January 31, 2024 was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The results of operations for the three and nine months ended October 31, 2024 are not necessarily indicative of the results to be expected for the year ending January 31, 2025 .
Fiscal Year	O ur fiscal year ends on January 3 1. References to fiscal 2025, for example, are to the fiscal year ending January 31, 2025 . Certain prior year amounts have been reclassified to conform to current year presentation. These amounts were not material to any of the prior periods presented.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the condensed consolidated financial statements and notes thereto. Significant items subject to such estimates and assumptions made by management include, but are not limited to, the determination of: • the fair value of intangible assets acquired in business combinations; • the average period of benefit associated with deferred contract acquisition costs and fulfillment costs; • the fair value of certain stock awards issued; • the useful life and recoverability of long-lived assets; • the discount rate used for operating leases; • the recognition and measurement of loss contingencies; and • the recognition, measurement and valuation of deferred income taxes.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which enhances disclosures required for operating segments. ASU 2023-07 expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. All disclosure requirements of ASU 2023-07 are required for entities with a single reportable segment. ASU 2023-07 is effective for annual filings for the Company’s fiscal year beginning February 1, 2024, and interim filings for the fiscal year beginning February 1, 2025, and should be applied on a retrospective basis to all periods presented. We are currently evaluating the effect of adopting ASU 2023-07 on our financial statement disclosures. In December 2023, the FASB issued Accounting Standards Update 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), amending existing income tax disclosure guidance, primarily requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation. ASU 2023-09 is effective for annual reporting periods beginning after December 15, 2024, with early adoption permitted and can be applied on either a prospective or retrospective basis. We are currently evaluating the effect of adopting ASU 2023-09 on our income tax disclosures. In March 2024, the SEC adopted the final rules under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors, which requires registrants to provide certain climate-related information in their registration statements and annual reports. As it pertains to the financial statements, the final rules require the financial statement footnotes to include certain disclosures regarding the amounts of expenses (or capitalized costs) incurred that relate to severe weather events and other natural conditions, as well as other disclosures regarding the material impact on financial estimates and assumptions of severe weather events and other natural conditions or disclosed targets or disclosed targets or transition plans. It also requires disclosure of financial statement amounts related to carbon offsets and renewable energy credits. The disclosure requirements will be phased in beginning with our annual filing for the fiscal year ending January 31, 2026. In April 2024, the SEC issued an order staying these rules pending the completion of judicial review of litigation challenging the validity of the rules. We are currently evaluating the disclosure impact of adoption of the standard on our consolidated financial statements. In November 2024, the FASB issued Accounting Standards Update 2024-03, "Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40)" (“ASU 2024-03”), which requires more detailed information about the types of expenses included in certain expense captions presented on the consolidated statements of operations. Additionally, this amendment requires the disclosure of a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively and the disclosure of the total amount of selling expenses. ASU 2024-03 is effective for annual filings for the Company's fiscal year beginning February 1, 2027, and interim filings for the fiscal year beginning February 1, 2028, and can be applied either prospectively or retrospectively. Early adoption is permitted. We are currently evaluating the effect of adopting ASU 2024-03 on our financial statements. We have not adopted accounting pronouncements during the three and nine months ended October 31, 2024.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Revenues by Geographic Area	Revenue by geographic area was as follows: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2024 2023 2024 2023 U.S. $ 543,294 $ 515,050 $ 1,585,472 $ 1,516,092 International 211,526 185,371 615,015 533,404 Total revenue $ 754,820 $ 700,421 $ 2,200,487 $ 2,049,496

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table summarizes our financial assets that are measured at fair value on a recurring basis: October 31, 2024 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 131,736 $ — $ — $ 131,736 Level 2: Cash equivalents (1) Commercial paper 1,982 — (1) 1,981 Available-for-sale securities Commercial paper 66,970 28 (16) 66,982 Corporate notes and bonds 363,651 625 (416) 363,860 U.S. governmental securities 13,485 2 (18) 13,469 Level 2 total 446,088 655 (451) 446,292 Total $ 577,824 $ 655 $ (451) $ 578,028 January 31, 2024 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 298,517 $ — $ — $ 298,517 Level 2: Cash equivalents (1) Commercial paper 43,845 — (9) 43,836 U.S. government agency securities 9,968 — (1) 9,967 Available-for-sale securities Commercial paper 42,958 2 (25) 42,935 Corporate notes and bonds 299,166 262 (670) 298,758 U.S. governmental securities 28,752 — (66) 28,686 Level 2 total 424,689 264 (771) 424,182 Total $ 723,206 $ 264 $ (771) $ 722,699 (1) Included in “cash and cash equivalents” in our consolidated balance sheets as of October 31, 2024 and January 31, 2024, in addition to cash of $477.2 million and $444.8 million.
Schedule of Fair Value of Available-for-sale Marketable Securities by Remaining Contractual Maturities	The fair values of our available-for-sale securities as of October 31, 2024, by remaining contractual maturities, were as follows (in thousands): Due in one year or less $ 331,506 Due in one to two years 112,805 $ 444,311

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment, net consisted of the following: (in thousands) October 31, 2024 January 31, 2024 Computer and network equipment $ 137,477 $ 142,241 Software, including capitalized software development costs 255,047 168,584 Furniture and office equipment 19,231 18,196 Leasehold improvements 63,776 58,230 475,531 387,251 Less: Accumulated depreciation (293,152) (244,270) 182,379 142,981 Work in progress 96,244 102,192 Total $ 278,623 $ 245,173

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Oct. 31, 2024
Business Combinations [Abstract]
Schedule of Assets Acquired And Liabilities Assumed	The following table summarizes preliminary allocation of purchase consideration to assets acquired and liabilities assumed based on their respective estimated fair values as of the date of acquisition: (in thousands) May 31, 2024 Cash and cash equivalents $ 10,409 Accounts receivable, net 1,741 Goodwill 103,352 Intangible assets, net 50,200 Contract liabilities — current (5,071) Deferred tax liability (5,862) Accrued expenses and other current liabilities (749) Total purchase consideration $ 154,020
Schedule of Identifiable Intangible Assets Estimated Useful Lives	The estimated useful lives of intangible assets, primarily based on the expected period of benefit to us, and fair values of the identifiable intangible assets at Acquisition Date were as follows: (in thousands, except years) Estimated Fair Value Expected Useful Life Existing technology $ 29,900 5.0 years Customer relationships—subscription 20,300 7.0 years Total intangible assets $ 50,200 5.8 years
Schedule of Unaudited Pro Forma Results	The unaudited pro forma results have been prepared based on estimates and assumptions, which we believe are reasonable, however, they are not necessarily indicative of the consolidated results of operations had the acquisition occurred on February 1, 2023, or of future results of operations: (in thousands) (unaudited) Three Months Ended October 31, Nine Months Ended October 31, 2023 2023 Net income/(loss) 21,799 23,916

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	9 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Carrying Amount of Goodwill	The changes in the carrying amount of goodwill were as follows (in thousands): Balance at January 31, 2024 $ 353,138 Additions—Lexion 103,352 Cumulative translation adjustment (812) Balance at October 31, 2024 $ 455,678
Schedule of Intangible Assets	Intangible assets consisted of the following: As of October 31, 2024 As of January 31, 2024 (in thousands, except years) Weighted-average Remaining Useful Life (Years) Acquisition-related Intangibles, Gross Accumulated Amortization Acquisition-related Intangibles, Net Acquisition-related Intangibles, Gross Accumulated Amortization Acquisition-related Intangibles, Net Existing technology 4.0 $ 106,094 $ (74,479) $ 31,615 $ 76,194 $ (65,777) $ 10,417 Customer contracts & related relationships 5.1 130,382 (70,043) 60,339 110,082 (60,947) 49,135 Other 0.0 22,534 (22,534) — 22,534 (22,534) — 4.7 $ 259,010 $ (167,056) 91,954 $ 208,810 $ (149,258) 59,552 Cumulative translation adjustment (8,647) (8,647) Total $ 83,307 $ 50,905
Schedule of Amortization of Finite-Lived Intangible Assets	Amortization of finite-lived intangible assets was as follows: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2024 2023 2024 2023 Cost of subscription revenue $ 3,566 $ 2,070 $ 8,703 $ 6,787 Sales and marketing 3,354 2,629 9,096 7,888 Total $ 6,920 $ 4,699 $ 17,799 $ 14,675
Schedule of Future Amortization of Finite-Lived Intangibles	As of October 31, 2024, future amortization of finite-lived intangibles that will be recorded is estimated as follows, excluding cumulative translation adjustment: Fiscal Period: Amount (in thousands) 2025, remainder $ 6,919 2026 21,535 2027 19,398 2028 16,938 2029 13,191 Thereafter 13,973 Total $ 91,954

Deferred Contract Acquisition_2

Deferred Contract Acquisition and Fulfillment Costs (Tables)	9 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Deferred Contract Acquisition and Fulfillment Costs	The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Nine Months Ended October 31, (in thousands) 2024 2023 Deferred Contract Acquisition Costs: Beginning balance $ 409,658 $ 355,389 Additions to deferred contract acquisition costs 183,040 143,321 Amortization of deferred contract acquisition costs (143,769) (114,151) Cumulative translation adjustment (2,942) (1,212) Ending balance $ 445,987 $ 383,347 Deferred Contract Fulfillment Costs: Beginning balance $ 22,525 $ 21,076 Additions to deferred contract fulfillment costs 31,508 33,189 Amortization of deferred contract fulfillment costs (28,962) (33,630) Cumulative translation adjustment 73 (268) Ending balance $ 25,144 $ 20,367

Debt (Tables)

Debt (Tables)	9 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Schedule of Interest Expense	Interest expense recognized related to the Notes was as follows: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2024 2023 2024 2023 Contractual interest expense $ — $ 22 $ — $ 425 Amortization of transaction costs — 1,089 — 3,308 Total $ — $ 1,111 $ — $ 3,733

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Contractual Obligations	As of October 31, 2024, our future noncancelable minimum payments due under these contractual obligations with a remaining term of more than one year were as follows: Fiscal Period: Amount (in thousands) 2025, remainder $ 12,095 2026 52,740 2027 11,490 2028 1,663 2029 1,138 Thereafter 483 Total $ 79,609

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Schedule of RSU Activity	RSU activity for the nine months ended October 31, 2024 was as follows: (in thousands, except per share data) Number of Units Weighted-Average Grant Date Fair Value Unvested at January 31, 2024 26,700 $ 60.70 Granted 12,638 57.90 Vested (6,991) 69.14 Canceled (3,138) 66.67 Unvested at October 31, 2024 29,209 $ 56.67
Schedule of Options Activity	Option activity for the nine months ended October 31, 2024 was as follows: (in thousands, except years and per share data) Number of Options Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at January 31, 2024, all vested and exercisable 1,385 $ 17.39 2.63 $ 60,117 Exercised (661) 17.17 Canceled/expired (1) 13.43 Outstanding at October 31, 2024, all vested and exercisable 723 $ 17.61 1.94 $ 37,216

Restructuring and Other Relat_2

Restructuring and Other Related Charges (Tables)	9 Months Ended
	Oct. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Liabilities	Restructuring liability activities during the nine months ended October 31, 2024: (in thousands) January 31, 2024 Accruals Cash Payments October 31, 2024 2024 Restructuring Plan Other 122 — (122) — Total $ 122 $ — $ (122) $ — 2025 Restructuring Plan Employee termination benefits $ — $ 24,874 $ (24,658) $ 216 Total $ — $ 24,874 $ (24,658) $ 216

Net Income per Share Attribut_2

Net Income per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Oct. 31, 2024
Earnings Per Share [Abstract]
Schedule of Calculation of Basic and Diluted Net Income Per Share Attributable to Common Stockholders	The following table presents the calculation of basic and diluted net income per share attributable to common stockholders for periods presented: Three Months Ended October 31, Nine Months Ended October 31, (in thousands, except per share data) 2024 2023 2024 2023 Numerator: Net income attributable to common stockholders, basic $ 62,423 $ 38,805 $ 984,394 $ 46,739 Add: Interest expense on convertible senior notes — $ 22 — 425 Net income attributable to common stockholders, diluted $ 62,423 $ 38,827 $ 984,394 $ 47,164 Denominator: Weighted-average common shares outstanding, basic 203,567 204,456 204,674 203,609 Effect of dilutive securities 5,139 3,598 5,081 4,708 Weighted-average common shares outstanding, diluted 208,706 208,054 209,755 208,317 Net income per share attributable to common stockholders: Basic $ 0.31 $ 0.19 $ 4.81 $ 0.23 Diluted $ 0.30 $ 0.19 $ 4.69 $ 0.23
Schedule of Antidilutive Securities	Outstanding potentially dilutive securities that were excluded from the diluted per share calculations because they would have been antidilutive are as follows: Three Months Ended October 31, Nine Months Ended October 31, (in thousands) 2024 2023 2024 2023 RSUs 2,879 22,913 3,011 13,045 ESPP 120 — 288 — Total antidilutive securities 2,999 22,913 3,299 13,045

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligations	$ 2,300		$ 2,300
Contract assets	$ 13.6		13.6		$ 15.9
Revenue recognized that was included in contract liability balance at the beginning of the period			$ 1,200	$ 1,100
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	56%		56%
Remaining performance obligations, period of recognition	12 months		12 months
Product Concentration Risk | Revenue | Subscription
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Concentration risk percentage	97%	97%	97%	97%

Revenue - Schedule of Revenues

Revenue - Schedule of Revenues by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 754,820	$ 700,421	$ 2,200,487	$ 2,049,496
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	543,294	515,050	1,585,472	1,516,092
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 211,526	$ 185,371	$ 615,015	$ 533,404

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	$ 577,824	$ 723,206
Gross Unrealized Gains	655	264
Gross Unrealized Losses	(451)	(771)
Estimated Fair Value	578,028	722,699
Cash	477,200	444,800
Level 2 | Available-for-sale securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	446,088	424,689
Gross Unrealized Gains	655	264
Gross Unrealized Losses	(451)	(771)
Estimated Fair Value	446,292	424,182
Money market funds | Level 1 | Cash Equivalents
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	131,736	298,517
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	131,736	298,517
Commercial paper | Level 2 | Cash Equivalents
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	1,982	43,845
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1)	(9)
Estimated Fair Value	1,981	43,836
Commercial paper | Level 2 | Available-for-sale securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	66,970	42,958
Gross Unrealized Gains	28	2
Gross Unrealized Losses	(16)	(25)
Estimated Fair Value	66,982	42,935
Corporate notes and bonds | Level 2 | Available-for-sale securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	363,651	299,166
Gross Unrealized Gains	625	262
Gross Unrealized Losses	(416)	(670)
Estimated Fair Value	363,860	298,758
U.S. governmental securities | Level 2 | Cash Equivalents
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost		9,968
Gross Unrealized Gains		0
Gross Unrealized Losses		(1)
Estimated Fair Value		9,967
U.S. governmental securities | Level 2 | Available-for-sale securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amortized Cost	13,485	28,752
Gross Unrealized Gains	2	0
Gross Unrealized Losses	(18)	(66)
Estimated Fair Value	$ 13,469	$ 28,686

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Fair Value of Available-for-sale Marketable Securities by Remaining Contractual Maturities (Details) - Short-term Investments $ in Thousands	Oct. 31, 2024 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Due in one year or less	$ 331,506
Due in one to two years	112,805
Total available-for-sale securities	$ 444,311

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 278,623		$ 278,623		$ 245,173
Depreciation expense	20,700	$ 18,600	61,300	$ 56,800
Capitalized computer software, amortization	14,300	9,500	39,400	25,100
Capitalized software costs	29,800	26,500	81,300	70,400
Capitalized stock-based compensation	10,000	$ 8,800	27,700	$ 22,500
Property and equipment, excluding work in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	475,531		475,531		387,251
Less: Accumulated depreciation	(293,152)		(293,152)		(244,270)
Property and equipment, net	182,379		182,379		142,981
Computer and network equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	137,477		137,477		142,241
Software, including capitalized software development costs
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	255,047		255,047		168,584
Furniture and office equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	19,231		19,231		18,196
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	63,776		63,776		58,230
Work in progress
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 96,244		$ 96,244		$ 102,192

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - Lexion Inc. - USD ($)		9 Months Ended
	May 31, 2024	Oct. 31, 2024
Business Acquisition [Line Items]
Business acquisition, percentage of voting interests acquired	100%
Payments to acquire business, gross	$ 154,000,000
Business combination consideration transferred cash contributed to escrow accounts	$ 17,400,000
Escrow account, holding period	18 months
Goodwill, expected tax deductible amount	$ 0
Business combination, consideration transferred, deferred compensation	$ 19,100,000
Business combination, consideration transferred, amortization period	3 years
Fair value of shares issued as consideration for acquisition	$ 34,800,000
Acquisition costs		$ 4,300,000

Acquisitions - Schedule of Asse

Acquisitions - Schedule of Assets Acquired And Liabilities Assumed (Details) - USD ($) $ in Thousands	Oct. 31, 2024	May 31, 2024	Jan. 31, 2024
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]
Goodwill	$ 455,678		$ 353,138
Lexion Inc.
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]
Cash and cash equivalents		$ 10,409
Accounts receivable, net		1,741
Goodwill		103,352
Intangible assets, net		50,200
Contract liabilities — current		(5,071)
Deferred tax liability		(5,862)
Accrued expenses and other current liabilities		(749)
Total purchase consideration		$ 154,020

Acquisitions - Schedule of Iden

Acquisitions - Schedule of Identifiable Intangible Assets Estimated Useful Lives (Details) - Lexion Inc. $ in Thousands	May 31, 2024 USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Fair Value	$ 50,200
Expected Useful Life	5 years 9 months 18 days
Existing technology
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Fair Value	$ 29,900
Expected Useful Life	5 years
Customer relationships—subscription
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Fair Value	$ 20,300
Expected Useful Life	7 years

Acquisitions - Schedule of Unau

Acquisitions - Schedule of Unaudited Pro Forma Results (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2023
Lexion Inc.
Business Acquisition, Pro Forma Information [Abstract]
Net income/(loss)	$ 21,799	$ 23,916

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Schedule of Carrying Amount of Goodwill (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2024 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 353,138
Cumulative translation adjustment	(812)
Ending balance	455,678
Lexion Inc.
Goodwill [Roll Forward]
Additions—Lexion	$ 103,352

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Finite-Lived Intangible Assets, Net [Abstract]
Weighted-average Remaining Useful Life (Years)	4 years 8 months 12 days
Acquisition-related Intangibles, Gross	$ 259,010	$ 208,810
Accumulated Amortization	(167,056)	(149,258)
Total	91,954	59,552
Cumulative translation adjustment	(8,647)	(8,647)
Acquisition-related Intangibles, Net	$ 83,307	50,905
Existing technology
Finite-Lived Intangible Assets, Net [Abstract]
Weighted-average Remaining Useful Life (Years)	4 years
Acquisition-related Intangibles, Gross	$ 106,094	76,194
Accumulated Amortization	(74,479)	(65,777)
Total	$ 31,615	10,417
Customer contracts & related relationships
Finite-Lived Intangible Assets, Net [Abstract]
Weighted-average Remaining Useful Life (Years)	5 years 1 month 6 days
Acquisition-related Intangibles, Gross	$ 130,382	110,082
Accumulated Amortization	(70,043)	(60,947)
Total	$ 60,339	49,135
Other
Finite-Lived Intangible Assets, Net [Abstract]
Weighted-average Remaining Useful Life (Years)	0 years
Acquisition-related Intangibles, Gross	$ 22,534	22,534
Accumulated Amortization	(22,534)	(22,534)
Total	$ 0	$ 0

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Schedule of Amortization of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Amortization of finite-lived intangible assets	$ 6,920	$ 4,699	$ 17,799	$ 14,675
Cost of subscription revenue
Finite-Lived Intangible Assets [Line Items]
Amortization of finite-lived intangible assets	3,566	2,070	8,703	6,787
Sales and marketing
Finite-Lived Intangible Assets [Line Items]
Amortization of finite-lived intangible assets	$ 3,354	$ 2,629	$ 9,096	$ 7,888

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net - Schedule of Future Amortization of Finite-Lived Intangibles (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jan. 31, 2024
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]
2025, remainder	$ 6,919
2026	21,535
2027	19,398
2028	16,938
2029	13,191
Thereafter	13,973
Total	$ 91,954	$ 59,552

Deferred Contract Acquisition_3

Deferred Contract Acquisition and Fulfillment Costs (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Capitalized Contract Cost, Net [Roll Forward]
Amortization of deferred contract acquisition costs	$ (172,731)	$ (147,781)
Deferred Contract Acquisition Costs:
Capitalized Contract Cost, Net [Roll Forward]
Beginning balance	409,658	355,389
Additions to deferred contract acquisition costs	183,040	143,321
Amortization of deferred contract acquisition costs	(143,769)	(114,151)
Cumulative translation adjustment	(2,942)	(1,212)
Ending balance	445,987	383,347
Deferred Contract Fulfillment Costs:
Capitalized Contract Cost, Net [Roll Forward]
Beginning balance	22,525	21,076
Additions to deferred contract acquisition costs	31,508	33,189
Amortization of deferred contract acquisition costs	(28,962)	(33,630)
Cumulative translation adjustment	73	(268)
Ending balance	$ 25,144	$ 20,367

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	1 Months Ended		3 Months Ended		9 Months Ended
	Jan. 31, 2021	Sep. 30, 2018	Jan. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	May 31, 2023
Debt Conversion [Line Items]
Repayments of convertible senior notes			$ 689,900,000	$ 37,100,000	$ 0	$ 37,083,000
Convertible Senior Notes Due 2023 | Convertible Debt
Debt Conversion [Line Items]
Principal on face amount of debt		$ 575,000,000
Debt interest rate percentage		0.50%
Proceeds from issuance of debt		$ 560,800,000
Debt instrument, effective interest rate					1%
Convertible Senior Notes Due 2023 | Convertible Debt | Capped Calls
Debt Conversion [Line Items]
Settlement of capped calls, net of related costs				$ 23,700,000		$ 23,700,000
Convertible Senior Notes Due 2024 | Convertible Debt
Debt Conversion [Line Items]
Principal on face amount of debt	$ 690,000,000
Debt interest rate percentage	0%
Proceeds from issuance of debt	$ 677,300,000
Debt instrument, effective interest rate					0.60%
Credit Facility | Revolving Credit Facility
Debt Conversion [Line Items]
Line of credit, maximum borrowing capacity							$ 500,000,000
Line of credit, additional borrowing amount							$ 250,000,000
Carrying value of debt					$ 0
Credit Facility | Revolving Credit Facility | Minimum
Debt Conversion [Line Items]
Line of credit, commitment fee percentage on undrawn balance					0.25%
Credit Facility | Revolving Credit Facility | Maximum
Debt Conversion [Line Items]
Line of credit, commitment fee percentage on undrawn balance					0.30%

Debt - Schedule of Interest Exp

Debt - Schedule of Interest Expense (Details) - Convertible Debt - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Debt Instrument [Line Items]
Contractual interest expense	$ 0	$ 22	$ 0	$ 425
Amortization of transaction costs	0	1,089	0	3,308
Total	$ 0	$ 1,111	$ 0	$ 3,733

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	Oct. 31, 2024 USD ($) putative_case	Jul. 19, 2022 stayed_case
Other Commitments [Line Items]
Letters of credit outstanding	$ 0.6
Number of putative shareholder derivative cases filed | putative_case	8
Number of cases stayed by court order | stayed_case		2
Cloud Computing Service Provider, Agreement Through Fiscal 2027
Other Commitments [Line Items]
Minimum commitment	$ 13.2
Cloud Computing Service Provider, Agreement Through Fiscal 2028
Other Commitments [Line Items]
Minimum commitment	$ 83.1

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Contractual Obligations (Details) $ in Thousands	Oct. 31, 2024 USD ($)
Purchase Obligation, Fiscal Year Maturity [Abstract]
2025, remainder	$ 12,095
2026	52,740
2027	11,490
2028	1,663
2029	1,138
Thereafter	483
Total	$ 79,609

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) shares in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024 USD ($) plan shares	Oct. 31, 2023 USD ($) shares	Oct. 31, 2024 USD ($) plan shares	Oct. 31, 2023 USD ($) shares	May 31, 2024 USD ($)	Sep. 30, 2023 USD ($)	Mar. 31, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock-based compensation plans | plan	3		3
Unrecognized compensation cost, options	$ 0		$ 0
Employee stock purchase plan, compensation expense			$ 460,388,000	$ 455,831,000
Stock repurchase program, authorized amount							$ 200,000,000
Stock repurchase program, additional authorized amount					$ 1,000,000,000	$ 300,000,000
Repurchases of common stock (in shares) | shares	2.9	1.8	9.2	3.1
Repurchases of common stock	$ 172,948,000	$ 75,035,000	$ 523,747,000	$ 145,515,000
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, RSUs	1,200,000,000		$ 1,200,000,000
Unrecognized compensation cost, remaining weighted-average period for recognition			2 years 9 months 25 days
RSUs | Market Based and Performance Based Vesting Conditions
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date fair value of unvested RSU's	154,800,000		$ 154,800,000
Performance vesting percentage			100%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee stock purchase plan, compensation expense	$ 3,300,000	$ 4,200,000	$ 9,900,000	$ 12,800,000
2018 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved for future issuance (in shares) | shares	38.9		38.9
2018 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved for future issuance (in shares) | shares	11.8		11.8

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of RSU Activity (Details) - RSUs shares in Thousands	9 Months Ended
	Oct. 31, 2024 $ / shares shares
Number of Units
Unvested at beginning of period (in shares) | shares	26,700
Granted (in shares) | shares	12,638
Vested (in shares) | shares	(6,991)
Canceled (in shares) | shares	(3,138)
Unvested at end of period (in shares) | shares	29,209
Weighted-Average Grant Date Fair Value
Unvested at beginning of period (in usd per share) | $ / shares	$ 60.70
Granted (in usd per share) | $ / shares	57.90
Vested (in usd per share) | $ / shares	69.14
Canceled (in usd per share) | $ / shares	66.67
Unvested at end of period (in usd per share) | $ / shares	$ 56.67

Stockholders' Equity - Schedu_2

Stockholders' Equity - Schedule of Options Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2024 USD ($) $ / shares shares	Jan. 31, 2024 USD ($) $ / shares shares
Number of Options
Beginning balance (in shares) | shares	1,385
Exercised (in shares) | shares	(661)
Canceled/expired (in shares) | shares	(1)
Ending balance (in shares) | shares	723	1,385
Weighted-Average Exercise Price Per Share
Beginning balance (in usd per share) | $ / shares	$ 17.39
Exercised (in usd per share) | $ / shares	17.17
Canceled/expired (in usd per share) | $ / shares	13.43
Ending balance (in usd per share) | $ / shares	$ 17.61	$ 17.39
Weighted-Average Remaining Contractual Term (Years)
Outstanding balance	1 year 11 months 8 days	2 years 7 months 17 days
Aggregate Intrinsic Value
Outstanding balance | $	$ 37,216	$ 60,117

Restructuring and Other Relat_3

Restructuring and Other Related Charges - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring and other related charges	$ 0	$ 710	$ 29,721	$ 30,293
Stock-based compensation expense			460,388	455,831
Employee termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring and other related charges			29,700	28,700
Stock-based compensation expense			$ 4,800	$ 5,000

Restructuring and Other Relat_4

Restructuring and Other Related Charges - Schedule of Restructuring Liabilities (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2024 USD ($)
2024 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring, beginning balance	$ 122
Accruals	0
Cash Payments	(122)
Restructuring, ending balance	0
2025 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring, beginning balance	0
Accruals	24,874
Cash Payments	(24,658)
Restructuring, ending balance	216
Other | 2024 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring, beginning balance	122
Accruals	0
Cash Payments	(122)
Restructuring, ending balance	0
Employee termination benefits | 2025 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring, beginning balance	0
Accruals	24,874
Cash Payments	(24,658)
Restructuring, ending balance	$ 216

Net Income per Share Attribut_3

Net Income per Share Attributable to Common Stockholders - Schedule of Calculation of Basic and Diluted Net Income Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Numerator:
Net income attributable to common stockholders, basic	$ 62,423	$ 38,805	$ 984,394	$ 46,739
Add: Interest expense on convertible senior notes	0	22	0	425
Net income attributable to common stockholders, diluted	$ 62,423	$ 38,827	$ 984,394	$ 47,164
Denominator:
Weighted-average common shares outstanding, basic (in shares)	203,567	204,456	204,674	203,609
Effect of dilutive securities (in shares)	5,139	3,598	5,081	4,708
Weighted-average common shares outstanding, diluted (in shares)	208,706	208,054	209,755	208,317
Net income per share attributable to common stockholders:
Basic (in usd per share)	$ 0.31	$ 0.19	$ 4.81	$ 0.23
Diluted (in usd per share)	$ 0.30	$ 0.19	$ 4.69	$ 0.23

Net Income per Share Attribut_4

Net Income per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	2,999	22,913	3,299	13,045
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	2,879	22,913	3,011	13,045
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	120	0	288	0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Provision (benefit) from income tax	$ 9,151	$ (2,971)	$ (804,340)	$ 17,198
Release of valuation allowance			837,700
Unrecognized tax benefits	71,100		71,100
Unrecognized tax benefits that would impact effective tax rate	$ 58,800		$ 58,800